Protein: Tropomyosin 3 (A0A2R2Y2Q3)
Organism: Homo sapiens (Human)
Function: Not known
InterPro domains:
- IPR000533: Tropomyosin (family) [68-284]
Sequence:
MMEAIKKKMQMLKLDKENALDRAEQAEAEQKQAEERSKQLEDELAAMQKKLKGTEDELDKYSEALKDAQEKLELAEKKAADAEAEVASLNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIENRALKDEEKMELQEIQLKEAKHIAEEADRKYEEVARKLVIIEGDLERTEERAELAESRCREMDEQIRLMDQNLKCLSAAEEKYSQKEDKYEEEIKILTDKLKEAETRAEFAERSVAKLEKTIDDLEDELYAQKLKYKAISEELDHALNDMTSI
Predicted GO terms:
Molecular Function (MF): GO:0003674 (molecular function), GO:0005488 (binding), GO:0005515 (protein binding)
Biological Process (BP): GO:0008150 (biological process), GO:0050789 (regulation of biological process), GO:0032501 (multicellular organismal process), GO:0065007 (biological regulation), GO:0050896 (response to stimulus), GO:0032502 (developmental process), GO:0009987 (cellular process), GO:0048519 (negative regulation of biological process), GO:0048869 (cellular developmental process), GO:0048856 (anatomical structure development), GO:0007275 (multicellular organism development), GO:0009653 (anatomical structure morphogenesis), GO:0042221 (response to chemical), GO:0071840 (cellular component organization or biogenesis), GO:0051239 (regulation of multicellular organismal process), GO:0048646 (anatomical structure formation involved in morphogenesis), GO:0003008 (system process), GO:0050793 (regulation of developmental process), GO:0050794 (regulation of cellular process), GO:0040013 (negative regulation of locomotion), GO:0051716 (cellular response to stimulus), GO:0030029 (actin filament-based process), GO:0006950 (response to stress), GO:0048523 (negative regulation of cellular process), GO:0040012 (regulation of locomotion), GO:0032989 (cellular component morphogenesis), GO:0048729 (tissue morphogenesis), GO:0044085 (cellular component biogenesis), GO:2000145 (regulation of cell motility), GO:0048468 (cell development), GO:0006979 (response to oxidative stress), GO:0030154 (cell differentiation), GO:0048731 (system development), GO:0008285 (negative regulation of cell population proliferation), GO:0044057 (regulation of system process), GO:0048513 (animal organ development), GO:1901700 (response to oxygen-containing compound), GO:0003205 (cardiac chamber development), GO:0030036 (actin cytoskeleton organization), GO:0003013 (circulatory system process), GO:0003012 (muscle system process), GO:0061061 (muscle structure development), GO:0009887 (animal organ morphogenesis), GO:0042127 (regulation of cell population proliferation), GO:0009888 (tissue development), GO:0070887 (cellular response to chemical stimulus), GO:0033554 (cellular response to stress), GO:0022603 (regulation of anatomical structure morphogenesis), GO:0003206 (cardiac chamber morphogenesis), GO:0016043 (cellular component organization), GO:0010927 (cellular component assembly involved in morphogenesis), GO:2000146 (negative regulation of cell motility), GO:0034599 (cellular response to oxidative stress), GO:0022604 (regulation of cell morphogenesis), GO:0060415 (muscle tissue morphogenesis), GO:0008015 (blood circulation), GO:0055001 (muscle cell development), GO:0062197 (cellular response to chemical stress), GO:0006936 (muscle contraction), GO:0048644 (muscle organ morphogenesis), GO:0003231 (cardiac ventricle development), GO:0090257 (regulation of muscle system process), GO:0030334 (regulation of cell migration), GO:0030239 (myofibril assembly), GO:0048662 (negative regulation of smooth muscle cell proliferation), GO:1903522 (regulation of blood circulation), GO:0030336 (negative regulation of cell migration), GO:0022607 (cellular component assembly), GO:0048660 (regulation of smooth muscle cell proliferation), GO:0003208 (cardiac ventricle morphogenesis), GO:0003007 (heart morphogenesis), GO:0042692 (muscle cell differentiation), GO:0072359 (circulatory system development), GO:0060537 (muscle tissue development), GO:0003015 (heart process), GO:0007517 (muscle organ development), GO:0006996 (organelle organization), GO:0031032 (actomyosin structure organization), GO:1901701 (cellular response to oxygen-containing compound), GO:0000302 (response to reactive oxygen species), GO:0097435 (supramolecular fiber organization), GO:0007507 (heart development), GO:0070925 (organelle assembly), GO:0008360 (regulation of cell shape), GO:0006937 (regulation of muscle contraction), GO:1904705 (regulation of vascular associated smooth muscle cell proliferation), GO:0014912 (negative regulation of smooth muscle cell migration), GO:0014706 (striated muscle tissue development), GO:0048738 (cardiac muscle tissue development), GO:0060047 (heart contraction), GO:0055008 (cardiac muscle tissue morphogenesis), GO:1904706 (negative regulation of vascular associated smooth muscle cell proliferation), GO:0014910 (regulation of smooth muscle cell migration), GO:0045214 (sarcomere organization), GO:0007010 (cytoskeleton organization), GO:0006941 (striated muscle contraction), GO:0008016 (regulation of heart contraction), GO:0051146 (striated muscle cell differentiation), GO:0034614 (cellular response to reactive oxygen species), GO:0055002 (striated muscle cell development), GO:0055010 (ventricular cardiac muscle tissue morphogenesis), GO:0060048 (cardiac muscle contraction), GO:0140694 (non-membrane-bounded organelle assembly), GO:0003229 (ventricular cardiac muscle tissue development), GO:1904752 (regulation of vascular associated smooth muscle cell migration)
Cellular Component (CC): GO:0005575 (cellular component), GO:0110165 (cellular anatomical entity), GO:0005829 (cytosol), GO:0005622 (intracellular anatomical structure), GO:0043226 (organelle), GO:0005737 (cytoplasm), GO:0043229 (intracellular organelle), GO:0043228 (non-membrane-bounded organelle), GO:0043232 (intracellular non-membrane-bounded organelle), GO:0005856 (cytoskeleton), GO:0015629 (actin cytoskeleton)